Anal Cancer

Nivolumab Shows Promise Against Aggressive Anal Cancer

By

Clinical trial results are promising for the use of nivolumab to treat squamous cell carcinoma of the anal canal, according to data presented at the 2016 American Association for Cancer Research Annual Meeting.

High-risk HPV Infection Increases Risk for Anal Cancer

By

Anal cancer is associated with human papillomavirus (HPV) infection, and some women are at increased likelihood of have both diseases.

HPV16 seropositivity common before anal cancer diagnosis

HPV16 seropositivity common before anal cancer diagnosis

Human papillomavirus type 16 seropositivity is fairly common before an anal cancer diagnosis, according to a study, and seropositivity tends to increase in blood samples drawn closer to time of cancer diagnosis.

HPV16 seropositivity relatively common prior to diagnosis of anal cancer

HPV16 seropositivity relatively common prior to diagnosis of anal cancer

Human papillomavirus (HPV) type 16 (HPV16) seropositivity is relatively common in people prior to receiving a diagnosis of anal cancer.

Despite cART, anal cancer risk still high for HIV-infected

Despite cART, anal cancer risk still high for HIV-infected

High incidence compared to general population, especially for men who have sex with men.

No benefit of induction chemo, high-dose boost in anal cancer

No benefit of induction chemo, high-dose boost in anal cancer

Colostomy-free survival not improved in patients with locally advanced anal canal carcinoma.

Cancer risk doubles for organ-transplant recipients

Compared with the general population, recipients of a kidney, liver, heart, or lung transplant have twice as great a risk for diverse infection-related and unrelated cancers.

HPV vaccine protects men from anal cancer

A quadrivalent human papillomavirus (HPV) vaccine to prevent anal cancer was shown to be safe and effective in a trial of healthy men who have sex with men.

IMRT a less toxic form of radiation in anal cancer

A novel chemoradiation regimen for the treatment of anal cancer is proven to have fewer significant side effects than conventional therapy.

HPV vaccine gets nod for prevention of anal cancer

The FDA has approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions caused by HPV for males and females aged 9 through 26 years.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs